Skip to main content
Figure 1 | Cardiovascular Diabetology

Figure 1

From: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

Figure 1

Associations between plasma levels of MMPs, TIMP-1 and CVD. Point estimates and 95% confidence intervals show the difference in plasma levels of lnMMP or TIMP-1 (in SD) in patients with vs. those without CVD resulting from a multivariable regression model including all cardiovascular risk factors, albuminuria and retinopathy (model 2).

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840